Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy

NCT03007407 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

NETWORK

Sponsor class

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG: durvalumab
DRUG: Tremelimumab

Sponsor

NSABP Foundation Inc